What I am most excited about is:
Bile tract cancer expansion trial opened and is expected to enroll approximately 10
patients; preliminary early data is expected in the second half 2024. - appreciate them giving us a timeline for data release!
That's what we have FDA fast track status for.
Given the sale of the facility (which I think was financially responsible), this should set us up to be well into 2025 prior to a CR (or deal with BP). Who knows what results we will have tabled by then...
Go you good thing.
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-24
-
- There are more pages in this discussion • 96 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.9¢ |
Change
0.001(2.08%) |
Mkt cap ! $364.4M | |||
| Open | High | Low | Value | Volume |
| 4.8¢ | 5.0¢ | 4.8¢ | $458.6K | 9.378M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 1039220 | 4.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.0¢ | 5436876 | 20 |
View Market Depth
| Last trade - 16.10pm 07/10/2024 (20 minute delay) ? |
| IMU (ASX) Chart |